Obesity-Related Complications and Management
Pathophysiology and Prevalence
- OSA prevalence reaches 56-70% in obese individuals, and obesity is the strongest modifiable risk factor for OSA development 1, 2
- The association between obesity and insulin resistance creates a metabolic milieu that promotes both OSA and hirsutism through hyperandrogenism 4, 2
- Chronic intermittent hypoxia from OSA worsens insulin resistance, creating a vicious cycle with obesity 4, 5
Clinical Approach and Diagnosis
- Confirm OSA with overnight polysomnography to quantify severity using apnea-hypopnea index (AHI >5 diagnostic, >15 requires treatment) 6, 1, 3
- Screen for secondary causes of hypertension, including thyroid function tests given the OSA-hypothyroidism association in women 6, 4, 2
- Assess for metabolic syndrome components, including fasting glucose, HbA1c, and lipid panel given the insulin resistance association 4, 5
Treatment and Management
- Weight loss is a crucial intervention that improves OSA severity, hypertension, insulin resistance, and hirsutism, although the exact mechanism is not fully understood 5
- CPAP therapy for confirmed OSA reduces cardiovascular events and improves blood pressure control, particularly with >4 hours nightly use 5
- Antihypertensive therapy should be optimized, recognizing that OSA-related hypertension is often resistant to treatment 7, 1, 5
Critical Considerations
- The American Heart Association recommends screening for OSA in all hypertensive patients, especially those with obesity, as up to 60% of resistant hypertension has underlying OSA 1, 3
- The Endocrine Society suggests considering PCOS as the likely cause of hirsutism in obese women with metabolic dysfunction, rather than rare adrenal causes 4, 2
- The American Thyroid Association advises screening for hypothyroidism, as it commonly coexists with OSA in women and contributes to the clinical picture 6, 4, 2